These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27434291)

  • 1. Decreased expression of LncRNA MIR31HG in human bladder cancer.
    He A; Chen Z; Mei H; Liu Y
    Cancer Biomark; 2016 Jul; 17(2):231-6. PubMed ID: 27434291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer.
    He A; Liu Y; Chen Z; Li J; Chen M; Liu L; Liao X; Lv Z; Zhan Y; Zhuang C; Lin J; Huang W; Mei H
    J Exp Clin Cancer Res; 2016 Aug; 35(1):125. PubMed ID: 27514530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer.
    Wu S; Nitschke K; Worst TS; Fierek A; Weis CA; Eckstein M; Porubsky S; Kriegmair M; Erben P
    J Exp Clin Cancer Res; 2020 Dec; 39(1):288. PubMed ID: 33334367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer.
    Chen T; Xie W; Xie L; Sun Y; Zhang Y; Shen Z; Sha N; Xu H; Wu Z; Hu H; Wu C
    Biochem Biophys Res Commun; 2015 Dec; 468(4):666-70. PubMed ID: 26551459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer.
    Lin J; Zhan Y; Liu Y; Chen Z; Liang J; Li W; He A; Zhou L; Mei H; Wang F; Huang W
    Oncotarget; 2017 Apr; 8(15):24202-24212. PubMed ID: 28445936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of long non‑coding RNA n346372 in bladder cancer tissues is associated with a poor prognosis.
    Liu A; Zhang Z; Xu W; Qin S; Hua M; Zeng S; Xu C
    Mol Med Rep; 2018 Dec; 18(6):5437-5444. PubMed ID: 30365104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of E-cadherin expression by lnc-RNA H19 to facilitate bladder cancer metastasis.
    Zhu Z; Xu L; Wan Y; Zhou J; Fu D; Chao H; Bao K; Zeng T
    Cancer Biomark; 2018; 22(2):275-281. PubMed ID: 29614625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differentially expressed long noncoding RNAs in bladder cancer.
    Peter S; Borkowska E; Drayton RM; Rakhit CP; Noon A; Chen W; Catto JW
    Clin Cancer Res; 2014 Oct; 20(20):5311-21. PubMed ID: 25165097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of LncRNA SRA1 in hepatocellular carcinoma and its clinical significance.
    Luo P; Jing W; Zhu M; Li ND; Zhou H; Yu MX; Liang CZ; Tu JC
    Cancer Biomark; 2017; 18(3):285-290. PubMed ID: 28085012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
    Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
    Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression.
    Jiang H; Hu X; Zhang H; Li W
    Radiat Oncol; 2017 Apr; 12(1):65. PubMed ID: 28376901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MIR31HG overexpression serves as poor prognostic biomarker and promotes cells proliferation in lung adenocarcinoma.
    Qin J; Ning H; Zhou Y; Hu Y; Yang L; Huang R
    Biomed Pharmacother; 2018 Mar; 99():363-368. PubMed ID: 29367106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma.
    Zhan Y; Li Y; Guan B; Chen X; Chen Z; He A; He S; Gong Y; Peng D; Liu Y; Cai Z; Li X; Zhou L
    Oncotarget; 2017 Jul; 8(27):44326-44334. PubMed ID: 28574830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased long noncoding RNA MIR31HG is correlated with poor prognosis and contributes to cell proliferation in gastric cancer.
    Nie FQ; Ma S; Xie M; Liu YW; De W; Liu XH
    Tumour Biol; 2016 Jun; 37(6):7693-701. PubMed ID: 26692098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LEIGC long non-coding RNA acts as a tumor suppressor in gastric carcinoma by inhibiting the epithelial-to-mesenchymal transition.
    Han Y; Ye J; Wu D; Wu P; Chen Z; Chen J; Gao S; Huang J
    BMC Cancer; 2014 Dec; 14():932. PubMed ID: 25496320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel antisense long noncoding RNA regulates the expression of MDC1 in bladder cancer.
    Xue Y; Ma G; Zhang Z; Hua Q; Chu H; Tong N; Yuan L; Qin C; Yin C; Zhang Z; Wang M
    Oncotarget; 2015 Jan; 6(1):484-93. PubMed ID: 25514464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of long non-coding RNAs that stimulate cell survival in bladder cancer.
    Dudek AM; Boer SJ; Boon N; Witjes JA; Kiemeney LALM; Verhaegh GW
    Oncotarget; 2017 May; 8(21):34442-34452. PubMed ID: 28415801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA expression profile in vulvar squamous cell carcinoma and its clinical significance.
    Ni S; Zhao X; Ouyang L
    Oncol Rep; 2016 Nov; 36(5):2571-2578. PubMed ID: 27633334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.